more info

Start date: 1 January 2020

End date: 31 December 2023

Number of projects: 1

Total budget: 5 778 837,62 €

EU contribution: 4 314 578,47 €

Website: n/a

Country:

European Commission Flag

Explore more: n/a

funds

ERDF: 4 314 578,47 €

EXPLORNA THERAPEUTICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Beneficiary Q2666404 of a Kohesio project

1 - 1 of 1

PROJECT

TOTAL BUDGET

EU CONTRIBUTION

FUND

Development of experimental anticancer immunotherapy based on therapeutic mRNA modified with innovative new generation cap analogues

5 778 837,62 €

4 314 578,47 €

ERDF